|
|
ChromosOmics - Database
|
-
CHROMOSOME 9 -
-
unclear if maternal or paternal UPD -
|
|
|
mat or pat
UPD-cases without clinical findings + normal karyotype
|
case no.
|
gender
|
age at diagnosis
|
studied
material
|
GTG-banding result
|
clinical symptoms
|
reference
|
09-
OU-N/
1-1
|
- |
- |
- |
- |
- |
- |
mosaic cases
case no.
|
gender
|
age at
diagnosis
|
studied
material
|
GTG-banding
result
|
clinical
symptoms
|
reference
|
09-
OU-N/
mos/
1-1
|
- |
- |
- |
- |
- |
- |
|
mat or pat UPD-cases without
clinical findings + balanced karyotype |
case no.
|
gender
|
age at diagnosis
|
studied
material
|
GTG-banding result
|
clinical symptoms
|
reference
|
09-
OU-bal/
1-1
|
- |
- |
- |
- |
- |
- |
|
mat or pat UPD-cases without
clinical findings + sSMC
|
case no.
|
case no. in
sSMC database
|
gender/
age at diagnosis
|
studied
material
|
GTG-banding
result
|
final FISH
result of the sSMC
|
FISH
methods
|
clinical
symptoms
|
reference
|
09-
OU-sSMC/
1-1
|
- |
- |
- |
- |
- |
- |
- |
- |
|
segmental
mat or pat UPD-cases without clinical findings
|
case no.
|
gender
|
age at diagnosis
|
studied
material
|
GTG-banding result
|
clinical symptoms
|
reference
|
09-
OU-seg/
pter/
2-1
|
n.a.
|
adult
|
PBL
|
n.a.; acc.
to array no imbalance in PBL
---
9pter to
9p24.1
|
normal adult
with gastrointestinal cancer
|
{1083}
case in Tab 3
|
mosaic cases
case no.
|
gender
|
age at
diagnosis
|
studied
material
|
GTG-banding
result
|
clinical
symptoms
|
reference
|
09-
OU-seg/
pter/
mos/
1-2
|
n.a.
|
adult
|
PBL
|
n.a.; acc. to
array no imbalance in PBL
---
9pter to
9p13.1 (in 83% of PBL)
|
normal adult
with bladder cancer
|
{545} case
586
|
|
mat or pat UPD-cases without clinical findings +
other imbalances |
case no.
|
gender
|
age at diagnosis
|
studied
material
|
GTG-banding result
|
clinical symptoms
|
reference
|
09-
OU-imb/
1-1
|
n.a.
|
adult
|
PBL
|
n.a. acc. to
array partial trisomy 9 and 22 in 72-74% of
PBL
---
9pter to
9p13.1
|
normal adult
with bladder cancer
|
{545} case 1185
|
mosaic cases
case no.
|
gender
|
age at
diagnosis
|
studied
material
|
GTG-banding
result
|
clinical
symptoms
|
reference
|
09-
OU-imb/
mos/
1-1
|
- |
- |
- |
- |
- |
- |
|
mat
or pat UPD-cases with or unclear clinical
correlation + normal karyotype |
case no.
|
gender
|
age at diagnosis
|
studied
material
|
GTG-banding result
|
clinical symptoms
|
reference
|
09-
WU-N/
1-1
|
n.a.
|
prenatal |
trophectoderm biopsies
|
n.a.
|
n.a.
|
{1131} |
01-
WU-N/
2-1 to 3-1
|
n.a.
|
postnatal
|
PBL
|
46,XN
|
different
neurodev. disorders
|
{1300}
2 cases
|
mosaic cases
case no.
|
gender
|
age at
diagnosis
|
studied
material
|
GTG-banding
result
|
clinical
symptoms
|
reference
|
09-
WU-N/
mos/
1-1
|
-
|
-
|
-
|
-
|
-
|
-
|
|
mat
or pat UPD-cases with or unclear clinical
correlation+ balanced karyotype
|
case no.
|
gender
|
age at diagnosis
|
studied
material
|
GTG-banding result
|
clinical symptoms
|
reference
|
09-
WU-bal/
1-1 |
-
|
-
|
-
|
-
|
-
|
-
|
|
mat
or pat UPD-cases with or unclear clinical findings +
sSMC
|
case no.
|
case no. in
sSMC database
|
gender/
age at diagnosis
|
studied
material
|
GTG-banding
result
|
final FISH
result of the sSMC
|
FISH
methods
|
clinical
symptoms
|
reference
|
09-
WU-sSMC/
1-1 |
- |
- |
- |
- |
- |
- |
- |
- |
|
segmental
mat or pat UPD-cases with or unclear clinical
correlation
|
case no.
|
gender
|
age at diagnosis
|
studied
material
|
GTG-banding result
|
clinical symptoms
|
reference
|
09-
WU-seg/
p13.3/
1-1
|
n.a.
|
n.a.
|
PBL
|
n.a.
---
9p13.3
(unclear if mat or pat origin)
|
classical
galactosaemia (gene GALT in 9p13.3)
|
{365}
|
09-
WU-seg/
p13.3/
1-1
|
male
|
1.3y
|
PBL
|
n.a.
---
1p31.1 to 1p22.1
and 9q22.2 to 9q31.2
|
medium-chain
acyl-CoA dehydrogenase
(MCAD) deficiency
(ACADM gene in 1p31.1) and
17β-HSD3
deficiency (HSD17B3 gene in 9q22.32)
|
{1448} case 2
|
mosaic cases
case no.
|
gender
|
age at
diagnosis
|
studied
material
|
GTG-banding
result
|
clinical
symptoms
|
reference
|
09-
WU-seg/
q13/
mos/
1-1
|
n.a.
|
4y
|
PBL
|
n.a.
---
9q13 to 9qter
67.03 Mb [hg19]
40% mos
|
autism
|
{1363} case
21
|
09-
WU-seg/
q13/
mos/
1-2
|
n.a.
|
prenatal
|
fibroblasts
|
n.a.
---
9q13 to 9qter
67.03 Mb [hg19]
40% mos
|
loss at 22 wog
|
{1363} case
22
|
|
mat
or pat UPD-cases with or unclear clinical
correlation + other imbalances |
case no.
|
gender
|
age at diagnosis
|
studied
material
|
GTG-banding result
|
clinical symptoms
|
reference
|
09-
WU-imb/
1-1
|
female
|
postnatal
|
PBL
|
47,XX,+9/46,XX
|
n.a.; blood
group system mixed
|
{778}
|
09-
WU-imb/
1-2
|
n.a.
|
n.a.
|
PBL
|
47,XN,+9[11%]/
46,XN[89%]
|
most likely
DYS and MR
size of UPD unclear
no gene identified
|
{828;
1170} 1 case
|
09-
WU-imb/
1-3 to 1-4
|
n.a.
|
prenatal
|
PBL
|
46,XN,+9
acc. to NIPT
|
TOP
|
{1389}
cases 118 and 139
|
09-
WU-imb/
1-5
|
n.a.
|
prenatal
|
PBL
|
46,XN,+9
acc. to NIPT
|
TOP
|
{1480} 1
case |
09-
WU-imb/
2-1
|
female
|
5y
|
PBL
|
n.a.
acc. to aCGH triplication of 9q21.11-q21.33
|
citrullinemia
(gene ASS1 in 9q34.11)
|
{828} 1
case
|
09-
WU-imb/
3-1
|
male
|
newborn
|
PBL
|
n.a. acc. to
aCGH copy number gains at
Xq28 and 10q26.11-
q26.12, copy number
loss at 16q23.1
|
3-methylglutaconic
aciduria, type I (gene AUH in 9q22.31)
|
{828} 1
case
|
09-
WU-imb/
4-1
|
n.a.
|
6y
|
PBL
|
aCGH x3:
9p22.3-9p21.3
iUPD: 9pter-9p22.3
|
DD
|
{1363} case 49 |
09-
WU-imb/
5-1
|
n.a.
|
prenatal
|
AF |
aCGH x3:
9p22.2p13.2
|
n.a.
|
{1496} case 2 |
mosaic cases
case no.
|
gender
|
age at
diagnosis
|
studied
material
|
GTG-banding
result
|
clinical
symptoms
|
reference
|
09-
WU-imb/
mos/
1-1
|
-
|
- |
- |
- |
- |
- |
|
|
|